SMALL CELL LUNG CARCINOMA
Clinical trials for SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Chemo-Immunotherapy duo outsmart tough lung cancer?
Disease control TerminatedThis phase II pilot trial is asking whether combining the chemotherapy drug gemcitabine with the immunotherapy drug nivolumab can shrink tumors in people with advanced small cell lung cancer that has spread and no longer responds to initial treatment. The study enrolls about 14 a…
Matched conditions: SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Lung cancer patients get new hope with Arginine-Starving drug combo
Disease control TerminatedThis study tests a three-drug combination (ADI-PEG 20, gemcitabine, and docetaxel) in people with lung cancer that has worsened after initial treatment. The goal is to find the safest dose and see if the combination can shrink tumors or slow disease progression. About 31 particip…
Matched conditions: SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New pill targets Hard-to-Treat cancers in early human test
Disease control TerminatedThis early-phase trial tested an experimental oral drug called NKT3447 in 23 adults with advanced or metastatic solid tumors that had stopped responding to standard treatments. The goal was to check safety, find the right dose, and see if the drug could shrink tumors. The study w…
Matched conditions: SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC